publication venue for
- Predictors of Placebo Induction Response and Remission in Ulcerative Colitis. S1542-3565(22)00811-4. 2022
- Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease. 20:1579-1587.e2. 2022
- Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis. 20:1588-1597.e3. 2022
- Reply. 20:e1510-e1511. 2022
- What is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Updated Systematic Review and Meta-analysis. S1542-3565(22)00594-8. 2022
- Clinical Decision Support Tool for Infliximab in Crohn’s Disease. 20:e1192-e1195. 2022
- Early Change in Epithelial Neutrophilic Infiltrate Predicts Long-Term Response to Biologics in Ulcerative Colitis. 20:1095-1104.e9. 2022
- Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life. 20:e945-e956. 2022
- Reply. 20:e1216-e1217. 2022
- Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. 19:2343-2352.e8. 2021
- Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019. 19:1355-1365.e4. 2021
- Reply. 19:1511-1511. 2021
- A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury. 19:1009-1019.e11. 2021
- Active Margins, Plexitis, and Granulomas Increase Postoperative Crohn’s Recurrence: Systematic Review and Meta-analysis. 19:451-462. 2021
- Real-World Gluten Exposure in Patients With Celiac Disease on Gluten-Free Diets, Determined From Gliadin Immunogenic Peptides in Urine and Fecal Samples. 19:484-491.e1. 2021
- Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn’s Disease: A Systematic Review and Pooled Meta-analysis. 19:238-245.e4. 2021
- The Risk of Contracting COVID-19 Is Not Increased in Patients With Celiac Disease. 19:391-393. 2021
- Leaving No Stone Unturned in the Search for Adverse Events Associated With Use of Proton Pump Inhibitors. 19:41-42. 2021
- Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies. 18:2143-2146. 2020
- Canadian Association of Gastroenterology Clinical Practice Guideline on the Management of Bile Acid Diarrhea. 18:24-41.e1. 2020
- Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—A Systematic Review and Meta-analysis. 17:2185-2198.e3. 2019
- Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. 17:1680-1713. 2019
- Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis. 17:1477-1488.e10. 2019
- Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis. 17:1040-1060.e11. 2019
- Reply. 17:1007-1007. 2019
- Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis. 17:411-418.e3. 2019
- Gastric Cancer as Preventable Disease. 15:1833-1843. 2017
- White Paper AGA: Functional Dyspepsia. 15:1191-1194. 2017
- Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation. 15:682-690. 2017
- Reply. 14:1672-1672. 2016
- A Model to Identify Sarcopenia in Patients With Cirrhosis. 14:1473-1480.e3. 2016
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. 14:1245-1255.e8. 2016
- Reply. 14:1361-1362. 2016
- Antidepressants for Functional Dyspepsia: New Indications for Old Therapies?. 14:393-394. 2016
- The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease. 13:928-935.e2. 2015
- Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial. 11:246-252.e5. 2013
- Partner Burden in Irritable Bowel Syndrome. 11:151-155. 2013
- Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis. 10:513-519. 2012
- Acid Suppression for Reflux Disease: “Off-the-Peg” or a Tailored Approach?. 10:210-213. 2012
- Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding. 10:234-239. 2012
- Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis. 9:762-768.e6. 2011
- Gastroesophageal Reflux Symptoms in Patients With Celiac Disease and the Effects of a Gluten-Free Diet. 9:214-219. 2011
- What Is the Prevalence of Clinically Significant Endoscopic Findings in Subjects With Dyspepsia? Systematic Review and Meta-analysis. 8:830-837.e2. 2010
- Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study. 8:800-805.e1. 2010
- Prevalence, Diagnosis, and Profile of Autoimmune Pancreatitis Presenting With Features of Acute or Chronic Pancreatitis. 8:639-640. 2010
- Spontaneous Intramural Esophageal Hematoma in Association With Idiopathic Thrombocytopenic Purpura: A Cause of Non-Cardiac Chest Pain. 8:e73-e74. 2010
- Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia. 8:401-409. 2010
- “Power” of Selective Serotonin Reuptake Inhibitors in Irritable Bowel Syndrome. 8:313-314. 2010
- Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. 7:1279-1286. 2009
- Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment. 7:524-529. 2009
- Not All Side Effects Associated With Tricyclic Antidepressant Therapy Are True Side Effects. 7:446-451. 2009
- Postinfectious Irritable Bowel Syndrome After a Food-Borne Outbreak of Acute Gastroenteritis Attributed to a Viral Pathogen. 5:457-460. 2007
- Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin. 4:1082-1089.e4. 2006
- Time Course and Pattern of Blood Loss With Ibuprofen Treatment in Healthy Subjects. 3:1075-1082. 2005
- Perceptions of Physicians and Patients With Organic and Functional Gastrointestinal Diagnoses. 2:121-126. 2004
- Perceptions of physicians and patients with organic and functional gastrointestinal diagnoses. 2:121-126. 2004
- Inflammatory Bowel Disease: Resource Utilization During Pediatric to Adult Transfer 2011